Zhenshun Cheng
发表论文 80 篇 · 总被引 63779 次 · h-index 30
代表论文
- Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. (2020 · Journal of the American Medical Association (JAMA) · 被引 21951)
- Azvudine is a thymus-homing anti-SARS-CoV-2 drug effective in treating COVID-19 patients (2021 · Signal Transduction and Targeted Therapy · 被引 184)
- Nrf2 Deficiency Exacerbated CLP-Induced Pulmonary Injury and Inflammation through Autophagy- and NF-κB/PPARγ-Mediated Macrophage Polarization (2022 · Cells · 被引 98)
- Favipiravir Versus Arbidol for Clinical Recovery Rate in Moderate and Severe Adult COVID-19 Patients: A Prospective, Multicenter, Open-Label, Randomized Controlled Clinical Trial (2021 · Frontiers in Pharmacology · 被引 79)
- High-flow nasal cannula versus conventional oxygen therapy in acute COPD exacerbation with mild hypercapnia: a multicenter randomized controlled trial (2022 · Critical Care · 被引 47)
- YAP1 protects against PM2.5-induced lung toxicity by suppressing pyroptosis and ferroptosis. (2023 · Ecotoxicology and Environmental Safety · 被引 36)